Inhibrx Biosciences INBX
NASDAQ INBX
$90.05 -0.56 (-0.62%)
As of: Nov 11, 2026 · 11:48 AM EST

Inhibrx Biosciences (INBX) Invested Capital (2023 - 2026)

Updated

Inhibrx Biosciences' Invested Capital came in at $123.31 million for Q2 2026, down 26.5% from $167.84 million a year earlier.

Analysis

Inhibrx Biosciences (INBX) Invested Capital (2023 - 2026) Analysis & Trends

For FY2025, Inhibrx Biosciences' Invested Capital was $108.55 million, down 18.7% from FY2024.

  • Going back by year, Invested Capital was $133.58 million in FY2024 (-46.7%) and $250.47 million in FY2023.
  • The five-year range for quarterly Invested Capital is $108.55 million (Q4 2025) to $250.47 million (Q4 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 89.77 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 126.18 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 76.32 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 98.72 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 45.14 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 68.36 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 39.27 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 151.97 Bn
10 Inhibrx Biosciences 1.33 Bn 760.41 Mn - 123.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 123.31 Mn
Mar 31, 2026 153.96 Mn
Dec 31, 2025 108.55 Mn
Sep 30, 2025 136.75 Mn
Jun 30, 2025 167.84 Mn
Mar 31, 2025 193.10 Mn
Dec 31, 2024 133.58 Mn
Sep 30, 2024 178.47 Mn
Jun 30, 2024 219.37 Mn
Dec 31, 2023 250.47 Mn
API Access

Inhibrx Biosciences Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=INBX&period=max&api_key=YOUR_API_KEY